Haiwang Capital
Asia, Shanghai, China, Shanghai'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Haiwang Capital is a platform for managing funds of Pudong Science and Technology Innovation Group.
Investor Profile
Haiwang Capital has backed more than 5 startups, with 3 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series Unknown, Series C rounds (top funding stages).
- Majority of deals are located in China.
- Strong thematic focus on Biotechnology, Pharmaceutical, Biopharma.
Stage Focus
- Series A (40%)
- Series Unknown (40%)
- Series C (20%)
Country Focus
- China (100%)
Industry Focus
- Biotechnology
- Pharmaceutical
- Biopharma
- Life Science
- Hardware
- Optical Communication
- Product Research
- Advanced Materials
- Manufacturing
- Semiconductor
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Haiwang Capital frequently co-invest with?
What are some of recent deals done by Haiwang Capital?
Find More Investors Like Haiwang Capital
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
